Main Session: New Drug Updates in Hematologic Malignancies: CAR T Cells, Targeted Therapeutics, and Other Agents

What are the most recently approved medications for managing hematologic malignancies?

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on hematologic cancers: drug updates.


Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.